Investing.com UK - Financial Markets Worldwide
50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

Twitter Blue Account Declares Eli Lilly Giving Away Free Insulin, Pharma Giant Says Its Fake

Published 12/11/2022, 16:08
Updated 12/11/2022, 17:10
© Reuters Twitter Blue Account Declares Eli Lilly Giving Away Free Insulin, Pharma Giant Says Its Fake
LLY
-
TWTR34
-

Benzinga - A fake account with the handle @EliLillyandCo posted last week on Twitter that Eli Lilly And Co (NYSE: LLY) is giving away free insulin.

Responding to the fake report, the company clarified that the account from which the message was sent was not the Twitter handle for the actual pharmaceutical giant. The company went on Twitter and apologized for the misleading tweet.

The Twitter account @EliLillyandCo had a blue check mark indicating the account was legitimate. Someone pretending to be the company spokesperson wrote, “We are excited to announce insulin is free now.”

According to a report, the fake Eli Lilly post has now been labeled a parody profile.

The incident now raises questions about Twitter CEO Elon Musk’s announcement of a subscription service by paying $8 monthly for the Twitter Blue mark.

The pranksters were able to create a fake account on Twitter by paying the amount and getting a blue mark announcing it as an authentic account.

Similarly, someone impersonated Lockheed Martin Corp (NYSE: NYSE:LMT), and using a fake Twitter Blue account, said the company was stopping weapons sales to a number of countries.

On Friday, the company's stock was down more than 5%.

Also Read: Twitter Co-Founder Jack Dorsey Apologizes For Layoffs: 'I Grew The Company Size Too Quickly'

Photo: Courtesy of shutterstock.com

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.